Discover · cnbc.com

No picture published by cnbc.com

Novo says Wegovy injection lowers BMI and obesity rates in children in trial

International: Top News And Analysis cnbc.com

This is what was read here when it was published. cnbc.com no longer carries it in what it publishes now.

Wegovy is already approved to treat obesity in children ages 12 and older, but there are currently no approved medications for those under 12.

More ways to use this
Open on another device
Scan this QR code to open the same public page

Scan to open this page. Your saved notes and account access are not included.

Download QR code

Open the page link

Keep going

Each of these is read from what this estate already kept: the feed a piece came through, the publisher behind it, the credits and topics the publisher printed. None of it is a recommendation, an identity or a record kept anywhere else.

Also from International: Top News And Analysis

  1. Gold's bad year is getting worse. Why its price keeps fallingcnbc.com
  2. Trump says U.S., China, Russia ‘uniquely positioned’ to discuss reducing nuclear weapons at historic meetingcnbc.com
  3. Anthropic IPO could create thousands of multimillionaire employeescnbc.com
  4. Nvidia interim CEO Kress tells employees ‘let’s move forward’ at first all-hands meeting since Jensen Huang exitcnbc.com
  5. Denmark ratifies Trump security deal over Greenland after months of diplomatic tensionscnbc.com
  6. Data center electricity use could double by 2030, IEA sayscnbc.com